Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-20-001895
Filing Date
2020-01-24
Accepted
2020-01-24 16:02:12
Documents
4
Effectiveness Date
2020-01-24

Document Format Files

Seq Description Document Type Size
1 S-8 achv-s8.htm S-8 196249
2 EX-5.1 achv-ex51_6.htm EX-5.1 13679
3 EX-23.2 achv-ex232_7.htm EX-23.2 2523
4 GRAPHIC gzz0quroy3fr000001.jpg GRAPHIC 8361
  Complete submission text file 0001564590-20-001895.txt   225353
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236059 | Film No.: 20545439
SIC: 2835 In Vitro & In Vivo Diagnostic Substances